Rami Manochakian/X
Feb 13, 2025, 08:53
Rami Manochakian: Osimertinib and Cardiotoxicity – a topic to keep addressing
Rami Manochakian, Vice President of the North American Neuroendocrine Tumor Society, shared two articles on X, commenting:
“Hot off the press.
Just published in Journal of Thoracic Oncology.
Real-World Study on Osimertinib-Related Cardiotoxicity.
‘The Risk and Reversibility of Osimertinib-Related Cardiotoxicity in a Real-World Population’
Authors: Minjung Bak, Hyukjin Park, Se-Hoon Lee, Seung Woo Park, Eun Kyoung Kim et al.
Along with an editorial on this important study and topic, my colleagues and I were pleased to write.”
“Osimertinib and Cardiotoxicity: A Topic to Keep Addressing”
Authors: Shenduo Li, Rami Manochakian, Yujie Zhao, Yanyan Lou.
More posts featuring Rami Manochakian.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 18, 2025, 17:19
Mar 18, 2025, 16:54
Mar 18, 2025, 16:25
Mar 18, 2025, 16:07
Mar 18, 2025, 14:56
Mar 18, 2025, 14:40